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Computer-assisted cognitive remediation
in adolescents with psychosis or at risk
for psychosis: a 6-month follow-up
Urben S, Pihet S, Jaugey L, Halfon O, Holzer L. Computer-assisted
cognitive remediation in adolescents with psychosis or at risk for
psychosis: a 6-month follow-up.
Objective: To investigate short-term outcomes of a computer-assisted
cognitive remediation (CACR) for adolescents with psychotic disorders or
at high risk for psychosis.
Method: Cognitive abilities and clinical status were assessed at baseline
(N = 32) and at 6-month follow-up (N = 22) after enrolment in either a
CACR (treatment group) or a computer games (control group) program
(8 weeks).
Results: With regard to the cognitive abilities, no amelioration was found
in the control group while, in the CACR group, significant improvements
in inhibition (p = 0.040) and reasoning (p = 0.005) were observed.
Furthermore, symptom severity decreased significantly in the control group
(p = 0.046) and marginally in the CACR group (p = 0.088).
Improvements in cognitive abilities were not associated with symptoms’
amelioration. Finally, increase in reasoning abilities was related to the
median effective work time in sessions of CACR (R = 0.64, p = 0.024).
Conclusion: At follow-up, enhanced cognitive abilities (reasoning and
inhibition), which are necessary for executing higher-order goals or
adapting behaviour to the ever-changing environment, were reported in
adolescents participants of the CACR. Thus, further studies are needed to
confirm and extend these interesting results.
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Significant outcomes
• This study presented a 6-month follow-up of a randomised single-blind controlled trial assessing a
computer-assisted cognitive remediation (CACR) in adolescents with psychotic disorders or at high
risk for psychosis.
• Short-term improvements in inhibition and reasoning abilities, independent of amelioration of
symptoms, were observed.
• Longer duration of CACR session was reported to be more effective in improving reasoning abilities,
raising questions about the dose-effect response of such treatment.
Limitations
• The small number of participants who completed the 6-month follow-up may limit the generalisation
of the results.
• Differential outcomes between psychotic and at high risk for psychosis could not be assessed.
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• Due to the absence of a ‘treatment as usual’ control group, the effects of the setting (computer use
in individual sessions) cannot be disentangled from those of the interventions offered in the day-care
centre.
Introduction
Impairments in a wide range of cognitive abilities
have been consistently reported in individuals with
psychotic disorders or schizophrenia (1–5). In addi-
tion, studies have supported that adolescent illness is
associated with a more severe form of schizophre-
nia and that the length of illness before treatment
is negatively related with long-term outcome (6).
Specifically, cognitive disabilities in adolescents with
psychotic disorders were found to be more severe
than in adults, contributing to less independence,
poorer educational achievement, vocational failure
and difficult social relationships later in adult life
(7,8). Furthermore, these cognitive impairments were
showed to be present before symptoms onset in indi-
viduals who later developed schizophrenia (9) indi-
cating the importance of studying adolescents at risk
for psychosis as well.
Although pharmacological treatment has been
shown to be effective in reducing psychotic symp-
toms, particularly positive ones, cognitive impair-
ments have mostly been resistant to such treatments
(10). Consequently, an important target of research
effort regarding psychotic disorders is the develop-
ment of effective methods for improving cognitive
abilities (11,12). Several reviews of studies, mainly
in adult with psychotic disorders (or schizophre-
nia), have indicated cognitive remediation therapy
(CRT) to be effective in reducing cognitive deficits
(13–18) with long-term benefits (19,20). Neverthe-
less, very few studies examined the effect of CRT,
and follow-up outcomes, in adolescents with psy-
chotic disorders or at high risk. Only two studies
have focused on young individuals (mean age under
20). The first study (21) conducted a 30-h CRT (in
addition to the usual psychoeducational treatment
program) in adolescents with psychotic disorders
(aged from 12 to 18). Although the results indicated
improvements in cognitive, clinical and psychosocial
domains, there were no gains in favour of the cogni-
tive remediation group compared to the control group
and there were no clear benefits at 1-year follow-
up (22). Another randomised controlled trial that
assessed the effectiveness of CRT (compared to treat-
ment as usual) in young patients with schizophre-
nia (aged from 14 to 22) found executive func-
tion (cognitive flexibility) and working memory
improvements at 6-month follow-up in favour of
the CRT group, compared to the control group
(8,23).
A specific form of CRT which seems to be
of particular interest for improving cognitive abil-
ities in adolescents is the CACR, which provides
a structured, flexible and standardised training with
clear, accurate and immediate feedback (24). Despite
the fact that a meta-analysis did not report higher
effect size for CACR compared to paper-and-pencil
CRT (16), many arguments could be offered in
favour of CACR. First, in adolescents, the use of
computer technology is an everyday reality associ-
ated with self-perceived competence which is likely
to enhance engagement in this form of cognitive
remediation (25). Furthermore, computer activities
are considered to improve opportunities for acquir-
ing new compensatory strategies, which represent
an important component of CRT (26). In addition,
prolonged multimedia stimulation is believed to
favour neural plasticity (27). In adult patients, CACR
programs have been shown to improve cognitive
deficits (28–32) as well as psychiatric status (28,31).
However, in adolescents with psychosis or at high
risk for psychosis, only one study, conducted by
our research group, has assessed CACR outcomes
[compared to playing with computer games (CGs)].
The complete analysis of the assessment after the
intervention was reported in details elsewhere (33)
and may be summarised as follows: improvements
in cognition, clinical symptoms and functional out-
comes in both groups, but a specific amelioration in
visuospatial abilities for the CACR group. Regret-
tably, the randomised controlled trial was designed
in such a way that the assessment after the pro-
gram and at follow-up was not strictly identical,
making it impossible to assess the stability of these
improvements. Nevertheless, no study has assessed
short-term benefits (i.e. 4 months after the comple-
tion of the program) of a CACR in adolescents with
psychotic disorders or at high risk for psychosis.
In this context, this study aims to assess short-term
outcomes of a CACR program on cognitive abilities
and clinical status in adolescents with psychotic dis-
orders or at high risk. The outcomes are compared
to a control program involving similar computer use
in an individualised setting.
Methods
Participants
Participants were outpatients, recruited in the Day
Care Unit for Adolescents in Lausanne. Informed
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consent was obtained from participants and their
guardians. To be included in the study participants
had to have (a) a diagnosis of psychotic disorder
according to the Diagnostic and Statistical Manual,
fourth edition (34), using the French version of Diag-
nostic Interview for Genetic Studies (35,36) or a
diagnosis of high risk of psychosis using the Struc-
tured Interview for Prodromal Symptoms and the
Scale of Prodromal Symptoms (37) and (b) a score
below the 10th percentile in at least one of five
domains of the Repeatable Battery for the Assess-
ment of Neuropsychological Status (38). Although
arbitrary, the 10th percentile was chosen based on
findings from our previous study as this threshold
best differentiated patients with psychotic disorders
from patients with psychotic disorders from patients
with other diagnoses (including mood disorder, anx-
iety disorders and conduct disorders) which were not
reported as having cognitive deficits (2). In addition,
the exclusion criteria were as follows: (a) mental
retardation (IQ < 70); (b) known neurological dis-
ease or developmental disability; (c) severe visual or
motor disorder that is incompatible with computer
use; (d) transient exclusion criteria: an acute clini-
cal state that could disrupt the CACR training or a
planned absence for more than 2 weeks during period
of intervention.
Thus, 32 adolescents (psychotic, N = 21; at high
risk for psychosis, N = 11) were considered in
the intention-to-treat population. Eighteen were ran-
domised to the treatment condition (CACR) and 14
to the control (CG). Twenty-two participants were
assessed at 6-month follow-up (12 in CACR group
and 10 in the CG). IQ estimation was obtained with
the French version of the National Adult Reading
Test (NART) (39). The majority of participants were
treated with antipsychotic medication. There were
no differences between groups in IQ, proportion of
male/female, proportion of psychotic/at risk for psy-
chosis and number of medicated adolescents and
number of years of completed education. The Table 1
reports the demographic, clinical characteristics and
the statistic tests.
Research design
The study was approved by the local ethics com-
mittee for human research. The design of this study
was a single blinded 8-week trial of CACR treat-
ment which was compared to CG. After a baseline
assessment and verifying inclusion criteria, partici-
pants were randomly assigned to treatment or con-
trol group. The psychologists who conducted the
neuropsychological assessment were blind to the
participant’s diagnosis and assignment group and
the research psychologists conducting the cognitive
Table 1. Demographic and clinical characteristics of the participants assessed at
follow-up
CACR group
(N = 12)
Control group
(N = 10)
Mean∗ SD Mean SD p†
Psychotic/at risk for psychosis 10/2 — 6/4 — 0.221
Male/female 7/5 — 7/3 — 0.675
Age 15.17 1.27 16.00 1.25 0.103
Years completed education 7.75 0.87 8.60 1.27 0.112
IQ 95.05 6.48 97.80 5.90 0.247
Medication (%) at follow-up 75.0 — 70.0 — 0.552
∗Means were reported for a more usual presentation of the data and because the
median (on which the nonparametric test were based) did not greatly differ from these
means.
†Chi-squared test or Mann-Whitney as appropriate.
training were also blind to the participant’s diagnosis.
Finally, data analyses were computed by an indepen-
dent researcher.
Computer-assisted cognitive remediation
The CACR program was based on the Captain’s Log
software (40). This program allows training in atten-
tion, concentration, memory, visuospatial, visuomo-
tor and conceptualisation with increasing difficulty.
Participants were administered two 45-min individual
sessions per week over 8 weeks (16 individual ses-
sions). Thirty-minute sessions of training have been
shown as effective in improving the cognitive func-
tioning of adults with psychotic disorders (28).
Computer game
A set of CGs (N = 13; essentially action CGs that
require attention and visuomotor skills) was offered
to patients assigned to the control group. The CG
program differed from the CACR program only in
content (CG instead of Captain’s Log software) while
the setting was the same (location, computer dura-
tion, frequency and trainer). The same psychologist
accompanied the patient during all the sessions. The
CGs were chosen by the participants and the research
psychologist provided encouragement and positive
feedback.
Outcome measures
Cognitive measures. A comprehensive test battery
(two different forms of each test were used when
it was possible) was administered by a trained neu-
ropsychologist at baseline and 6 months after com-
pleting the intervention program (either CACR or
CGs). The assessed cognitive functions (i.e. process-
ing speed, memory abilities and executive functions)
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were chosen according to previous studies which
reported alteration of these abilities (1,4,5).
Processing speed. The symbol coding test (WAIS-
III: >16 years old/WISC-IV: <16 years old) (41,42)
was used to assess processing speed abilities. In this
test, the participant had to decide if any of two targets
symbols were present in a set of five symbols. The
main measure was the number of symbols correctly
recognised in 120 s.
Working memory. In the letter-number sequenc-
ing (WAIS-III: >16 years old/WISC-IV: <16 years
old) (41,42), letters and numbers were presented to
the participants who had to recall it in the correct
order (alphabetic and increasing number). The mea-
sure is the largest span correctly recalled. In the ver-
bal and visuospatial digit span (WMS-III: >16 years
old/CMS: <16 years old) (43), the participant was
presented with clusters of random number sequences
of increasing length. They were asked to tell the num-
bers in forward and backward order, or show the
correct sequence of blocks (visuospatial span). The
measure was the number of correctly repeated items.
Long-term memory. The Hopkins Verbal Learning
Test-Revised (44) was used to assess verbal episodic
memory. This test consisted of a list of 12 nouns
(targets) with four words drawn from each of three
semantic categories. The test was administered by
reading the words aloud, then asking the individual
to verbally repeat the list of words (immediately and
after a delay) and to identify the words from the list
from a verbal presentation (including both the tar-
get words and the distractors). The measure was the
number of words correctly recalled.
The Brief Visuospatial Memory Test-Revised (45)
was used to assess visuospatial episodic memory.
Patients were presented with six geometric figures
printed in a 2 × 3 array on separate pages. In the
three learning trials, the participant viewed the stim-
ulus for 10 s and was then asked to draw as many
of the figures as possible in their correct location
on a page. After a 25-min delay which consisted
of primarily verbal activities, the task was repeated.
The measures were the number of correct responses
recalled.
Executive functions. The Color Stroop task (46)
was used to assess one aspect of executive function-
ing, known as inhibition abilities. In this test, the
participant had to suppress the highly overlearned
response of word reading in favour of the less auto-
matic process of colour naming. The measure was
the number of words processed in 120 s.
The verbal fluency task assessed initiation abilities
which are also part of the executive function abilities.
In this task, the participant were asked to generate as
many words as they could of one category (animals),
in a limited time (47). The measure was the number
of correct words expressed in 60 s.
Reasoning and planning abilities. The block design
test (WAIS-III/WISC-IV) (41,42) assessed reasoning
abilities. In this test, participants had to reproduce
abstract visuospatial patterns which increase in
difficulty. The measure is the number of patterns
correctly reproduced.
The Tower of London (48) was administered to
the participant in order to assess planning abilities.
This test consisted of moving coloured balls within
a limited number of moves in order to achieve a
given goal configuration. Levels of difficulty depend
on the number and complexity of subgoals required.
The measure was the total correct score.
For all cognitive tests, standard scores were
computed in order to control for age differences
and to have more clinical significance. Thus, higher
scores reflected better performances.
Symptoms assessment. The global clinical efficacy
of the program was assessed with the Clinical
Global Impression-Severity of illness scale and
Clinical Global Improvement (CGI) (49) which is
commonly used as a primary outcome measure in
pharmacological studies. The patient’s therapist who
was blind to his/her group attribution filled the CGI
scoring from 0 to 7.
Data analyses
The data’s distributions were explored using
Kolmogorov-Smirnov tests. Results revealed that
45% of the variables did not have a Gaussian dis-
tribution. Thus, in order to compute reliable tests,
we computed nonparametric analyses. First, the treat-
ment and the control groups were compared with
Mann-Whitney test at baseline in order to ensure
comparable performances on the cognitive mea-
sures and clinical outcome. Then, using Wilcoxon
signed rank tests, performances on cognitive tests
and clinical outcome at baseline were compared to
the measures at 6-month follow-up, separately for
each group. The between-group differences were
then assessed at follow-up with Mann-Whitney test.
After that, significant changes in cognitive measures
were correlated with Spearman’s Rho in order to
see whether improvement in cognitive measure was
related to changes in the severity of the symptom.
Correlation analyses were also conducted between
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Table 2. Baseline and follow-up results for completer participants
Baseline Follow-up
Variable Group Median (SD) N Median (SD) N p§
Processing speed
Symbol code CACR 6.50 (3.70) 12 9.50 (3.61) 12 0.195
Control 9.00 (4.47) 10 10.00 (3.01) 10 0.906
Working memory
Letter-number sequence CACR 7.00 (3.09) 12 8.00 (3.75) 12 0.385
Control 7.50 (1.77) 10 8.00 (2.78) 10 0.888
Verbal span CACR 7.50 (5.01) 12 6.50 (4.31) 12 0.918
Control 8.50 (2.80) 10 8.50 (2.26) 10 0.569
Visuospatial span CACR 11.00 (3.85) 12 10.00 (3.58) 12 0.325
Control 10.00 (3.23) 10 9.00 (3.25) 10 0.352
Episodic memory
Verbal memory CACR 35.00 (13.06) 12 38.50 (17.08) 12 0.720
Control 28.00 (15.59) 10 38.50 (18.27) 10 0.593
Visuospatial memory CACR 52.00 (15.19) 12 44.00 (16.58) 12 0.271
Control 59.00 (12.20) 10 59.00 (14.01) 10 0.786
Executive function
Stroop CACR 3.50 (1.56) 12 5.00 (2.10) 12 0.040†
Control 5.00 (1.90) 10 5.00 (1.65) 10 0.915
Fluency CACR 5.00 (0.89) 12 5.00 (1.14) 12 0.705
Control 5.00 (0.48) 10 5.00 (0.48) 10 1.000
Reasoning and planning
Block design CACR 8.00 (3.93) 12 8.50 (3.18) 12 0.005‡
Control 8.50 (4.70) 10 8.50 (3.67) 10 0.551
ToL CACR 100.00 (17.29) 12 103.00 (22.10) 12 0.778
Control 100.00 (13.75) 10 113.00 (18.35) 10 0.312
Symptoms
CGI CACR 5.00 (0.75) 12 5.00 (1.24) 12 0.088∗
Control 4.00 (0.84) 10 3.50 (1.43) 10 0.046†
∗p < .10; †p < .05; ‡p < .01.
§Wilcoxon signed rank test.
the median effective work time in CACR pro-
gram sessions and the significant changes in cogni-
tive abilities. Finally, completers and non-completers
(individuals who did not finish the study) were com-
pared at baseline with Mann-Whitney test.
Results
Table 2 summarises the performances of each group
at baseline and follow-up and the p-value of the
statistical tests.
At baseline, performances in the fluency task were
higher in the control group than in the CACR group
(U = 35.00, p = 0.024). In addition, the severity of
symptoms was higher in the CACR group (U =
27.50, p = 0.041).
Wilcoxon signed rank tests revealed significant
differences between baseline and follow-up, on exec-
utive function (Stroop test, p = 0.040, ηp2 = 0.348)
and reasoning abilities (block design test, p = 0.005,
ηp
2 = 0.621) with better performances at follow-up
only in the CACR group. In addition, the sever-
ity of the symptoms diminished (only marginally
significant, p = 0.088, ηp2 = 0.273) in the CACR
Fig. 1. Relationships between improvement in reasoning abil-
ities (changes in block design test: follow-up – baseline) and
median effective work time in sessions.
group as well as in the control group (p = 0.046,
ηp
2 = 0.400) between baseline and follow-up.
At follow-up, no significant between-group differ-
ences were found on the cognitive measures as well
as on the clinical outcome.
No significant correlations were observed between
changes in severity of symptoms and changes in the
cognitive measures that significantly improved. Fur-
thermore, the median effective work time in sessions
of CACR was positively correlated to changes in the
block design test (R = 0.64, p = 0.024, see Fig. 1).
Significant changes were not related to demographic
variables.
Significant differences were found at baseline
between participants who withdrew from the study
(non-completers) and those who completed the
follow-up (completers) on the symbol code (U =
42.50; p = 0.036; non-completers: median = 11.50,
SD = 4.73; completers: median = 8.00, SD = 4.13)
and in the block design test (U = 37.50; p = 0.027;
non-completers: median = 12.50, SD = 3.23; com-
pleters: median = 8.00, SD = 4.35) with the non-
completers showing better performances. However,
no differences were found regarding the severity
of the symptoms (p = 0.657) or group membership
(CACR or control, p = 0.959).
Discussion
This study aimed to explore the long-term outcomes
of a CACR in adolescents with psychotic disorders or
at high risk for psychosis. At baseline and 6 months
after baseline of a CACR or CG program, adoles-
cents were assessed with a comprehensive cogni-
tive battery and the severity of their symptoms was
reported by their therapist. Results revealed a specific
improvement, only in the CACR group, in executive
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function (inhibition abilities) and reasoning abilities,
which represent high-order cognitive capacities. Fur-
thermore, the effective duration of the CACR was
related to the magnitude of improvement in reasoning
abilities. Symptoms diminished in both groups, but
this improvement was independent of the cognitive
amelioration. This suggests that CACR has specific
effects on some of the investigated cognitive capac-
ities, while the setting (computer use in individual
sessions) and/or the treatment program provided in
the day-care centre have general effects on symp-
toms. Due to the absence of a ‘treatment as usual’
control group, the effects of the setting cannot be
disentangled from those of the ‘care as usual’ inter-
ventions. Finally, at baseline, non-completers showed
better performances than completers in processing
speed and in reasoning ability, and similar perfor-
mances in other tests, suggesting that our positive
findings do not result from a selection bias.
The observed improvement in high-order cognitive
abilities is consistent with previous randomised con-
trol trials in adolescents with schizophrenia (8,23)
which found a long-term improvement in executive
function (cognitive flexibility) and working memory.
When compared to studies with adults, these results
are consistent with a study reporting persistent benefit
(4 weeks after discharge) in problem-solving abili-
ties (20). Similarly, another study (19) that proposed
a 6-month cognitive remediation focused on work-
ing memory abilities, showed a sustained (6 months
after the end of the cognitive remediation program)
improvement in these abilities. In contrast, another
trial in adolescents with psychotic disorders did
not find specific improvements for their treatment
group (21,22) compared to psychoeducational train-
ing (i.e. traditional treatment in their centre) and did
not showed long-term benefits. Indeed, after control-
ling for IQ differences, no clear differences were
reported except for one test for which the participants
received direct training (22).
The long-term amelioration in abilities such as
inhibition and reasoning may allow the individual
to better adapt to a changing environment. Indeed,
executive functions (more specifically inhibition) are
required in order to pursue higher-order goals (50);
inhibiting an overlearned response in favour of a
non-dominant one represents a necessary step in
order to engage in new activities (51). Furthermore,
better reasoning abilities could be related to more
appropriate decision making. Indeed, it has been
shown (52), in healthy participants aged from 6 to
25 years of age, that increased proportional reasoning
ability could explain improvements in decision mak-
ing as measured by the standard Iowa Gambling Task
designed to mimic real-life decision making (53).
Thus, improving the reasoning abilities in adoles-
cents with psychotic disorders or at high risk could
help them make more appropriate decisions, which
may have important long-term benefits (e.g. in social
or educational domain) for their lives.
Although practice effects may have interfered
in the assessment of these abilities, they are
unlikely to have strongly influenced our results
for several reasons. First, the cognitive assessment
was done with two different versions of the tests,
and the repetition occurred after 6 months, which
may strongly limit practice effects. Second, results
revealed improvements only in the CACR group and
not in the control group. Therefore, practice effect is
not likely to have produced these results.
No significant relationship was found between
ameliorations in cognitive abilities and in symp-
toms’ severity. This result is consistent with previous
research in adults with schizophrenia (7) and in ado-
lescents with psychotic disorders (21,22) indicating
that improvements in these domains follow different
time-course.
A possible limitation is the small number of par-
ticipants who completed the study, which may have
restricted the power of the statistical analyses. How-
ever, this population is very difficult to recruit and to
assess several times. Moreover, the number of par-
ticipants in this study did not differ markedly from
that of the previous study assessing long-term out-
comes of cognitive remediation in a similar popula-
tion (N = 31 in the study of Wykes et al., N = 25
in the study of Ueland and Rund), underscoring
the relevance of this study. Given the preliminary
nature of these encouraging results, future research
on larger samples is needed to confirm the reported
improvements.
Although the heterogeneity of the studied pop-
ulation could be viewed as a possible limitation,
cognitive deficits has also been shown in the pro-
dromal phase of the pathology (9), emphasising the
need to develop effective interventions for those at
high risk for psychosis, whose adolescence process
might be impaired by their cognitive deficits. How-
ever, studies with large sample size are needed to
determine whether the CACR is similarly efficient
for adolescents with psychosis and for those at high
risk and whether CACR would prevent conversion
to psychosis.
The strengths of this study are its randomised
single-blind design and its focus on the short-
term outcomes of a CACR program, representing
an important topic which has received very little
attention. Indeed, it is of particular importance to
develop more appropriate treatments targeting cog-
nitive enhancement for adolescents with psychotic
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disorders or at high risk for psychosis, given that
they lie at a crucial period of development.
In conclusion, this trial reported long-term
improvements in high-order abilities specifically
related to an 8-week CACR program. These improve-
ments were not related to symptoms amelioration.
Thus, the CACR seems to be a useful tool for the
improvement of cognitive abilities, showing promis-
ing long-term benefits. Further studies with larger
sample are necessary to confirm the improvement
found in specific cognitive abilities.
Acknowledgements
This research was supported by a grant from the Swiss National
Science Foundation (no. 32003B_112160). The authors wish to
express their gratitude to Mrs Laure Perraudin, Aure´lie Aeber-
hard, Sonja Suter, Virginie Van Craenenbroek, Muriel Hafil,
Veronica Pellanda, Raffaella Torrisi and Sandra Barcellona for
their involvement in the project and conducting the interven-
tions, and to the patients for their participation in the study. The
authors declare no conflict of interest.
References
1. Asarnow RF, Asamen J, Granholm E, Sherman T,
Watkins JM, Williams ME. Cognitive/neuropsychological
studies of children with a schizophrenic disorder. Schizophr
Bull 1994;20:647–669.
2. Holzer L, Chinet L, Jaugey L et al. Detection of cog-
nitive impairment with the Repeatable Battery for the
Assessment of Neuropsychological Status (RBANS) in ado-
lescents with psychotic symptomatology. Schizophr Res
2007;95:48–53.
3. Kenny JT, Friedman L, Findling RL et al. Cogni-
tive impairment in adolescents with schizophrenia. Am
J Psychiatry 1997;154:1613–1615.
4. Kumra S, Wiggs E, Bedwell J et al. Neuropsycholog-
ical deficits in pediatric patients with childhood-onset
schizophrenia and psychotic disorder not otherwise speci-
fied. Schizophr Res 2000;42:135–144.
5. Rhinewine JP, Lencz T, Thaden EP et al. Neurocogni-
tive profile in adolescents with early-onset schizophrenia:
clinical correlates. Biol Psychiatry 2005;58:705–712.
6. Schulz SC, Findling RL, Friedman L, Kenny JT,
Wise AL. Treatment and outcomes in adolescents with
schizophrenia. J Clin Psychiatry 1998;59(Suppl. 1):50–54.
7. Bark N, Revheim N, Huq F, Khalderov V, Ganz ZW,
Medalia A. The impact of cognitive remediation on
psychiatric symptoms of schizophrenia. Schizophr Res
2003;63:229–235.
8. Wykes T, Newton E, Landau S, Rice C, Thomp-
son N, Frangou S. Cognitive remediation therapy (CRT)
for young early onset patients with schizophrenia: an
exploratory randomized controlled trial. Schizophr Res
2007;94:221–230.
9. Fuller R, Nopoulos P, Arndt S, O’Leary D, Ho BC,
Andreasen NC. Longitudinal assessment of premorbid
cognitive functioning in patients with schizophrenia through
examination of standardized scholastic test performance.
Am J Psychiatry 2002;159:1183–1189.
10. Nieuwenstein MR, Aleman A, de Haan EH. Relation-
ship between symptom dimensions and neurocognitive func-
tioning in schizophrenia: a meta-analysis of WCST and CPT
studies. Wisconsin Card Sorting Test. Continuous Perfor-
mance Test. J Psychiatr Res 2001;35:119–125.
11. Medalia A, Revheim N, Casey M. Remediation of mem-
ory disorders in schizophrenia. Psychol Med 2000;30:
1451–1459.
12. Bhatia T, Agarwal A, SHaah G et al. Adjunctive cog-
nitive remediation for schizophrenia using yoga: an open,
non-randomised trial. Acta Neuropsychiatrica (in press).
13. Krabbendam L, Aleman A. Cognitive rehabilitation in
schizophrenia: a quantitative analysis of controlled studies.
Psychopharmacology (Berl) 2003;169:376–382.
14. Kurtz MM, Moberg PJ, Gur RC, Gur RE. Approaches
to cognitive remediation of neuropsychological deficits in
schizophrenia: a review and meta-analysis. Neuropsychol
Rev 2001;11:197–210.
15. Pilling S, Bebbington P, Kuipers E et al. Psychological
treatments in schizophrenia: II. Meta-analyses of random-
ized controlled trials of social skills training and cognitive
remediation. Psychol Med 2002;32:783–791.
16. Twamley EW, Jeste DV, Bellack AS. A review of
cognitive training in schizophrenia. Schizophr Bull 2003;29:
359–382.
17. McGurk SR, Twamley EW, Sitzer DI, McHugo GJ,
Mueser KT. A meta-analysis of cognitive remediation in
schizophrenia. Am J Psychiatry 2007;164:1791–802.
18. Wykes T, Huddy V, Cellard C, McGurk SR, Czobor P.
A meta-analysis of cognitive remediation for schizophre-
nia: methodology and effect sizes. Am J Psychiatry
2011;168:472–485.
19. Bell M, Bryson G, Wexler BE. Cognitive remediation
of working memory deficits: durability of training effects in
severely impaired and less severely impaired schizophrenia.
Acta Psychiatr Scand 2003;108:101–109.
20. Medalia A, Revheim N, Casey M. Remediation of
problem-solving skills in schizophrenia: evidence of a
persistent effect. Schizophr Res 2002;57:165–171.
21. Ueland T, Rund BR. A controlled randomized treatment
study: the effects of a cognitive remediation program on
adolescents with early onset psychosis. Acta Psychiatr
Scand 2004;109:70–74.
22. Ueland T, Rund BR. Cognitive remediation for adoles-
cents with early onset psychosis: a 1-year follow-up study.
Acta Psychiatr Scand 2005;111:193–201.
23. Wykes T, Reeder C, Landau S et al. Cognitive remedia-
tion therapy in schizophrenia: randomised controlled trial.
Br J Psychiatry 2007;190:421–427.
24. Medalia A, Aluma M, Tryon W, Merriam AE. Effec-
tiveness of attention training in schizophrenia. Schizophr
Bull 1998;24:147–152.
25. Bremer J, Rauch PK. Children and computers: risks
and benefits. J Am Acad Child Adolesc Psychiatry
1998;37:559–560.
26. Kurtz MM, Seltzer JC, Shagan DS, Thime WR,
Wexler BE. Computer-assisted cognitive remediation in
schizophrenia: what is the active ingredient? Schizophr Res
2007;89:251–260.
27. Hogarty GE, Flesher S, Ulrich R et al. Cognitive
enhancement therapy for schizophrenia: effects of a 2-
year randomized trial on cognition and behavior. Arch Gen
Psychiatry 2004;61:866–876.
334
https:/www.cambridge.org/core/terms. https://doi.org/10.1111/j.1601-5215.2012.00651.x
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 30 May 2017 at 15:25:27, subject to the Cambridge Core terms of use, available at
CACR follow-up
28. Bellucci DM, Glaberman K, Haslam N. Computer-
assisted cognitive rehabilitation reduces negative symptoms
in the severely mentally ill. Schizophr Res 2003;59:225–232.
29. Burda PC, Starkey TW, Dominguez F, Vera V.
Computer-assisted cognitive rehabilitation of chronic psy
chiatric-inpatients. Comput Human Behav 1994;10:359–368.
30. Fisher M, Holland C, Merzenich MM, Vinogradov S.
Using neuroplasticity-based auditory training to improve
verbal memory in schizophrenia. Am J Psychiatry 2009;166:
805–811.
31. Medalia A, Aluma M, Tryon W, Merriam AE. Effec-
tiveness of attention training in schizophrenia. Schizophr
Bull 1998;24:147–152.
32. Grynszpan O, Perbal S, Pelissolo A et al. Efficacy
and specificity of computer-assisted cognitive remediation
in schizophrenia: a meta-analytical study. Psychol Med
2011;41:163–173.
33. Holzer L, Passini MC, Pellanda V et al. A randomised
controlled trial of the effectiveness of a computer-assisted
cognitive remediation (CACR) program in adolescents with
psychosis or at high risk of psychosis. Behav Res Ther
(submitted).
34. APA. Diagnostic and statistical manual of mental disorders
(DSM-IV), 4th edn. Washington (DC): American Psychi-
atric Association, 1994.
35. Nurnberger JI, Blehar MC, Kaufmann CA et al. Diag-
nostic interview for genetic-studies - rationale, unique fea-
tures, and training. Arch Gen Psychiatry 1994;51:849–859.
36. Preisig M, Fenton BT, Matthey ML, Berney A, Fer-
rero F. Diagnostic interview for genetic studies (DIGS):
inter-rater and test-retest reliability of the French version.
Eur Arch Psychiatry Clin Neurosci 1999;249:174–179.
37. Miller TJ, McGlashan TH, Woods SW et al. Symptom
assessment in schizophrenic prodromal states. Psychiatr Q
1999;70:273–287.
38. Randolph C, Tierney MC, Mohr E, Chase TN. The
Repeatable Battery for the Assessment of Neuropsycholog-
ical Status (RBANS): preliminary clinical validity. J Clin
Exp Neuropsychol 1998;20:310–319.
39. Mackinnon A, Mulligan R. The estimation of premor-
bid intelligence levels in French speakers. Encephale
2005;31:31–43.
40. Sanford JA, Brown RJ. Captain’s log cognitive system.
Richmond: Brain Train, Inc., 1988.
41. Wechsler D. WAIS III: Echelle d’intelligence pour adultes,
3e`me. Paris: ECPA, 1997.
42. Wechsler D. WISC IV: Echelle d’intelligence pour
enfants, 4e`me. Paris: ECPA, 2005.
43. Wechsler D. MEM III: Echelle clinique de me´moire de
Wechsler, 3e`me. Paris: ECPA, 1997.
44. Brandt J. The Hopkins Verbal Learning Test: development
of a new verbal memory test with six equivalent forms. Clin
Neuropsychol 2005;5:125–142.
45. Benedict RHB, Schretlen D, Groninger L, Dob-
raski M, Shpritz B. Revision of the brief visuospatial
memory test: studies of normal performance, reliability, and
validity. Psychol Assess 1996;8:145–153.
46. Stroop JR. Studies of interference in serial verbal reactions.
J Exp Psychol 1935;18:643–662.
47. Sauzeon H, Lestage P, Raboutet C, N’Kaoua B,
Claverie B. Verbal fluency output in children aged 7-16 as
a function of the production criterion: qualitative analysis
of clustering, switching processes, and semantic network
exploitation. Brain Lang 2004;89:192–202.
48. Krikorian R, Bartok J, Gay N. Tower of London proce-
dure: a standard method and developmental data. J Clin Exp
Neuropsychol 1994;16:840–850.
49. Guy W. ECDEU assessment manual. Rockville (Mary-
land): US Department of Health, Education and Welfare,
1976.
50. Miyake A, Friedman NP, Emerson MJ, Witzki AH,
Howerter A, Wager TD. The unity and diversity of
executive functions and their contributions to complex
“Frontal Lobe” tasks: a latent variable analysis. Cogn
Psychol 2000;41:49–100.
51. Logan GD. On the ability to inhibit thought and action:
a users’ guide to the stop signal paradigm. In: Dagen-
bach D, Carr TH, eds. Inhibitory processes in attention,
memory, and language. London: Academic Press Inc., 1994:
189–239.
52. Huizenga HM, Crone EA, Jansen BJ. Decision-making
in healthy children, adolescents and adults explained by the
use of increasingly complex proportional reasoning rules.
Dev Sci 2007;10:814–825.
53. Bechara A, Damasio AR, Damasio H, Anderson SW.
Insensitivity to future consequences following damage to
human prefrontal cortex. Cognition 1994;50:7–15.
335
https:/www.cambridge.org/core/terms. https://doi.org/10.1111/j.1601-5215.2012.00651.x
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 30 May 2017 at 15:25:27, subject to the Cambridge Core terms of use, available at
